BARD1, BRIP1, PALB2, RAD50, RAD51C, NBN, and MRE11A gene mutations have been implicated in OC as part of the BRCA2/Fanconi anaemia signalling pathway in the event of nil BRCA1 and/or BRCA2 mutations. This evidence concerns the gene BRCA2 and Fanconi anemia.